We hypothesize that the fish oils, EPA and DHA, can serve as effective chemopreventive agents against lung cancer and that this protective effect is mediated by selective alteration of arachidonate metabolism through cyclooxygenase enzymes to favor production of PGE3 rather than PGE2. The beneficial effect of PGE3 (i.e. inhibition of tumor cell proliferation vs stimulation produced by PGE2) is at present a poorly understood phenomenon. The research proposed in this application will help us determine the efficacy of fish oil against human lung cancer and obtain insight into the pharmacodynamic activity of EPA and DHA on normal and malignant lung epithelial cells.
The specific aims of this proposed project are as follows: 1. To compare the time and concentration-dependent inhibitory effect of EPA and DHA alone or in combination on growth of human lung tumor cells, including cells expressing high and low levels of COX-2. 2. To determine changes in eicosanoid metabolism in human normal and cancer lung cells resulting from exposure of cells to EPA and DHA. The relative effect of these fish oils will also be examined against purified human recombinant COX-1 or COX-2 enzymes using our new and highly specific LC/MS/MS method that simultaneously and rapidly determines prostaglandins (e.g. PGE2 and PGE3) as well as selected lipoxygenase enzyme products (5-, 8-, 11-, 12-, and 15-HETE as well as specific leukotrienes such as LTB4 and LTB5). 3. To compare the relative effect of PGE2 and PGE3 at physiological and pharmacological concentrations on lung cell proliferation and mobility. 4. To study the relationship of PGE2 and PGE3 on cell proliferation and motility relative to activation of the cAMP-PKA signaling pathway through prostanoid receptors in human normal and cancer cells, and 5. To evaluate the relative efficacy of EPA, DHA and fish oil (containing both fatty acids) in prevention of tumor growth and its correlation to alteration of eicosanoid metabolism in a mouse model of human lung cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21CA102411-01
Application #
6673955
Study Section
Special Emphasis Panel (ZAT1-CP (05))
Program Officer
Seifried, Harold E
Project Start
2003-08-01
Project End
2005-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
1
Fiscal Year
2003
Total Cost
$113,250
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Other Domestic Higher Education
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Yang, Peiying; Cartwright, Carrie; Chan, Diana et al. (2014) Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation. Mol Carcinog 53:566-77
Yang, Peiying; Chan, Diana; Felix, Edward et al. (2006) Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids. Prostaglandins Leukot Essent Fatty Acids 75:385-95